![](/img/cover-not-exists.png)
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Mir, Olivier, Brodowicz, Thomas, Italiano, Antoine, Wallet, Jennifer, Blay, Jean-Yves, Bertucci, François, Chevreau, Christine, Piperno-Neumann, Sophie, Bompas, Emmanuelle, Salas, Sébastien, Perrin, CLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30507-1
Date:
October, 2016
File:
PDF, 327 KB
english, 2016